Japanese pharmaceutical company Sumitomo Pharma announced on October 30 that the first patient to receive its newly approved regenerative medicine treatment for Parkinson's disease underwent a successful brain cell transplant at Kyoto University Hospital in early October, with the woman in her 50s already returning to work and recovering well. (News On Japan)